'Suicide gene E' reduces potent drug dosage in cancer patients

[News]

Researchers at the University of Granada have found a suicide gene, called 'gene E', which leads to the death of tumour cells derived from breast, lung and colon cancer, and prevents their growth. The importance of this new gene is that its use to fight cancer can reduce the potent drugs that are currently used, so that could mean more effective treatment for cancer.

More... (http://www.news-medical.net/news/20091125/Suicide-gene-E-reduces-potent-drug-dosage-in-cancer-patients.aspx)

[Laurel]

the most relevant fact was found in the breast cancer cell line MCF-7, in which the dose of the chemotherapeutic agent, doxorubicin, was reduced by 100 times, reaching up to a 21% greater inhibition of tumour proliferation when combined with gene E. Currently, researchers from the UGR are in the process of obtaining a patent for gene E.

Totally diggin' this!